(secondQuint)Curcumin in Combination With 5FU for Colon Cancer.

 Confirm clinical safety and identify clinical response rate of combination treatment with curcumin and 5FU in chemorefractory CRC patients.

 To determine whether curcumin administration induces systemic alterations in inflammatory and epigenetic biomarkers in patients with chemoresistant metastatic colorectal cancer (CRC).

 To correlate altered biomarker findings with clinical response according to RECIST V1.

1 and survival criteria.

.

 Curcumin in Combination With 5FU for Colon Cancer@highlight

The purpose of this study is to test the safety and find the response rate of combining the dietary supplement, curcumin, with the standard of care, FDA-approved chemotherapy drug 5-fluorouracil (5FU, Adracil) and see what effects (good and bad) that the combined treatments have on colon cancer.

